In the News
Office of Public Affairs, April 7, 2014
Mary Horowitz, MD, MS receives 2014 ASBMT Lifetime Achievement Award
By virtue of a unanimous decision from the American Society for Blood and Marrow Transplantation (ASBMT) Executive Committee, Mary Horowitz, MD, MS, was presented with the 2014 ASBMT Lifetime Achievement Award during the ASBMT Awards and Business Meeting on Feb. 28, 2014. Dr. Horowitz is the Robert A. Uihlein, Jr. Chair in Hematologic Research, Professor of Medicine and Chief of Hematology and Oncology. She serves as Chief Scientific Director of the Center for International Blood and Marrow Transplant Research (CIBMTR).
The award recognizes her ongoing involvement and support of the BMT community, in particular, her past, current and future stewardship of the CIBMTR and the CTN (Clinical Trials Network). The award was presented by C. Fred LeMaistre, MD, President of the ASBMT.
College News, March 5, 2014
Dr. James Thomas, MD, PhD discusses how the Triumph Fund will help MCW in expanding the cancer clinical trials.
Office of Public Affairs, February 18, 2014
Dr. Rizzo Notes that Oral Chemotherapy Drugs are Standard Practice Medications
In a Wisconsin Public Radio interview, Dr. Douglas Rizzo (Medicine – Hematology/Oncology) countered insurance company arguments that oral chemotherapy medications are “emerging” treatments that may not be effective. Dr. Rizzo noted that these are standard practice medications; some have been in use for over a decade.
Wisconsin Public Radio, November 14, 2013
Local Doctor Specializes in Rare Disease
TMJ4 interviewed Dr. Parameswaran Hari discussing Amyloidosis and how it is treated.
To view Dr. Hari's interview please click here
The Business Journal discusses a $1 million donation to Froedtert and the Medical College which opened The Nicholas Family Foundation Translational Research Unit which Dr. James Thomas discusses how the unit will help to expand and offer earlier clinical trials to cancer patients.
October 14, 2013